GILLESPIE-SYNDROME, ANIRIDIA IN A PREMATURE TWIN
Opgen-Rhein B.1,
Seibt I2, Schachinger H2
1Dept. of
Paediatrics, St. Josef-Krankenhaus, Berlin, Germany, 2Dept. of
Neonatology, EWK, Berlin, Germany.
OBJECTIVE:
Bilateral aniridia defined as dilated pupils and absent or hypoplastic rim of
the iris is a rare finding in newborn infants. We report an early diagnosis of
Gillespie's syndrome in a premature twin and discuss the differential
diagnosis.
Case report: We present a male twin with an
gestational age of 29 weeks suffering from severe Infant Respiratory Distress
Syndrome. Aniridia was detected on physical examination and was confirmed by an
ophthalmologist. There was no response to local miotics. Abdominal
ultrasonography revealed no nephroblastoma. Genetic tests showed no gross
abnormality especially, no deletion of the chromosome 1 Ip and no mutation of
the PAX6-gen. On early neurologic evaluation the child presents with
generalised decreased muscle tone, opisthotonus and nystagm. At follow-up at 6 month
there is ataxia, continuous rocking movements and rolling of both eyes.
DISCUSSION:
There are several known aetiologies of aniridia. Mutations of PAX6 llpl3 leads
to isolated aniridia (AN 2). The continuous gene syndrome called WAGR-syndrome
shows extensive deletion of llpl3 including WT 1 and is leading to the
association of aniridia, hemihypertrophy and other congenital anomalies
especially genitourinary defects and bilateral Wilms tumour.
So far there is no known genetic defect producing
Gillespie's-Syndrome. Patients are showing partial aniridia with 'festooned'
edge and iris strands extending to the anterior lens surface at regular
intervals. This finding is considered characteristic. Furthermore there is
retardation of psychomotoric development, cerebellar ataxia and mental
retardation. There may be cerebral and cerebellar hypoplasia with white matter
changes detectable later in infancy by MRI.
CONCLUSION:
Aniridia is a significant finding in newborn infants. A characteristic partial
aniridia and unexplained neurologic pathology should be suspicious for
Gillespie's syndrome and close developmental follow up should be initiated.
There is need for molecular genetic work-up to rule out AN 2 and WAGR-Syndrome.
Aniridia is treated symptomatic with self-regulating sunglasses or cataract
surgery.